Ovarian Rejuvenation
Turn back yourovarian clock.
A regenerative fertility option for women with even 0 AMH — to restore ovarian youth and get your own eggs back.
72%
Reported marker improvement reviewed over 3 months*
5
Global specialists across fertility and longevity care
1,000+
Complex ovarian reserve cases reviewed and treated
Report-ledAMH, FSH, AFC and prior IVF response are reviewed before treatment is considered.
Technique mattersPreparation quality, placement and protocol can influence response.
Monitored follow-upMarkers, scans and next-step planning are tracked after the procedure.
Clear consentRisks, limits and alternatives are discussed before you commit.
Up to 8x increase in AMH and ovarian function observed.
Made possible: live births in women above 45.
Care built for Indian women's biology and context, not adapted from a foreign template.
What is ovarian rejuvenation
Ovarian rejuvenation uses regenerative material from your own body to support the ovarian environment in carefully selected cases. It is not magic — response depends on case selection, technique, and post-care monitoring.
Revive
Supports ovarian tissue activity in selected low-reserve cases.
Wake
Aims to encourage healthier follicular activity where biology allows.
Protect
Pairs the procedure with careful timing, stimulation strategy and follow-up.
Two paths, one goal
Choosing your approach
Both approaches work with your own biology. The right one depends on your ovarian reserve, FSH/AMH/AFC pattern, previous IVF response, comfort with invasiveness, and what your specialist believes is realistic.
1Review
2Prepare
3Deliver
4Monitor
Approach
O-Renew PRP
- 1Reviews AMH, FSH, AFC, age and prior cycle response before confirming suitability
- 2Prepares platelet-rich plasma from your own blood in a controlled setting
- 3Delivers PRP to the ovaries using a minimally invasive, ultrasound-guided approach
- 4Tracks hormone markers, scan findings and next-step fertility planning after treatment
Is this for you
Who is ovarian rejuvenation for?
01
Women between 40–53 with very low AMH (<1.0)
Have very low AMH — including cases where AMH is reported as zero — or diminished ovarian reserve (DOR), and want to understand whether pursuing pregnancy with their own eggs is still reasonable.
02
Women younger than 40 with poor ovarian response
Have produced fewer eggs than expected in previous stimulation or IVF cycles and need a review of protocol, reserve and ovarian environment.
03
Egg or embryo quality concerns
Have repeated concerns around egg or embryo quality and want a plan that looks beyond a single lab value.
04
Premature ovarian insufficiency (POI) or menopause
Have POI, early menopause or hormonal transition symptoms and need careful counselling about limits, risks and realistic next steps.
The process
What to expect
Real results
What we measure after treatment
Patient · Age 34
AMHAnti-Müllerian Hormone
0.81.4 ng/mL
Lab reports
Before
After
Individual results vary. Ovarian rejuvenation is an emerging treatment and is not guaranteed to improve AMH, AFC, egg quality or pregnancy outcomes.
Who's guiding your care
Backed by the world's leading regenerative medicine experts
5 physicians and researchers across 3 countries, with case review focused on suitability, technique, stimulation strategy and post-procedure monitoring.
Dr. Elena Marsh
Reproductive endocrinologist
United States
Dr. Aiko Tanaka
Regenerative medicine specialist
Japan
Dr. Lukas Weber
Longevity researcher
Germany
Dr. Priya Nair
Fertility and IVF specialist
India
Dr. Rita Bakshi
Chairperson & IVF specialist
India
Questions
Frequently asked
Know your options.
Every case is different. Speak with a fertility coach to understand where you stand, and what path may work for you.